Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
In locally advanced ESCC patients, short-term survival after NCIT is superior to that after NCRT, with similar perioperative and pathological outcomes.
Authors
- Fangdong Zhao
- Chuangui Chen
- Zuoyu Chen
- Abbas E. Abbas (ORCID: https://orcid.org/0000-0002-5626-6866)
- Jie Yue (ORCID: https://orcid.org/0000-0003-0258-3310)
- Xiaofeng Duan (ORCID: https://orcid.org/0009-0004-8076-3055)
- Xiaobin Shang (ORCID: https://orcid.org/0000-0001-6769-2505)
- Qingsong Pang (ORCID: https://orcid.org/0000-0002-3576-6909)
- Zhao Ma
- Wencheng Zhang (ORCID: https://orcid.org/0000-0002-9416-6540)
- Hongjing Jiang
- Chen Zhang (ORCID: https://orcid.org/0000-0001-8706-1372)
Institutions
- Brown University (US)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Lifespan (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cam4.70113
- Citations
- 9
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.15
Funders
- Tianjin Medical University